{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:31:05Z","timestamp":1716078665849},"reference-count":46,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.3109\/10428194.2013.858149","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T10:28:10Z","timestamp":1382956090000},"page":"1758-1767","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Medical decision analysis for first-line therapy of chronic myeloid leukemia"],"prefix":"10.1080","volume":"55","author":[{"given":"Ursula","family":"Rochau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaby","family":"Sroczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Conrads-Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Saverno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Brixner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald","family":"Radich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guenther","family":"Gastl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"key":"CIT0001","unstructured":"Sox HC, Blatt MA, Higgins MC, et al. Medical decision making. Philadelphia, PA: American College of Physicians; 1997."},{"key":"CIT0002","unstructured":"Hunink MGM, Glasziou PP, Siegel JE, et al. Decision making in health and medicine: integrating evidence and values. Cambridge, UK: Cambridge University Press; 2001."},{"key":"CIT0003","unstructured":"Rabin R, Oemar M, Oppe M, et al. EuroQol Group [Internet]. EQ-5D-5L user guide. Basic information on how to use the EQ-5D-5L instrument. Rotterdam, The Netherlands: EuroQol Group; 2011. Available from: http:\/\/www.euroqol.org\/fileadmin\/user_upload\/Documenten\/PDF\/Folders_Flyers\/UserGuide_EQ-5D-5L.pdf"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9301300409"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12455463"},{"key":"CIT0007","unstructured":"Collett D. Modelling survival data in medical research. 2nd ed. Boca Raton, FL: Chapman & Hall\/CRC Press; 2003."},{"key":"CIT0008","doi-asserted-by":"crossref","unstructured":"Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. New York, NY: Oxford University Press; 2006.","DOI":"10.1093\/oso\/9780198526629.001.0001"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61165-9"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.3109\/10428191003637282"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005686"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22661"},{"issue":"1","key":"CIT0015","volume":"114","author":"Deininger M","year":"2009","journal-title":"Blood"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22569"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055229"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"CIT0020","volume-title":"Decision making in health and medicine: integrating evidence and values","author":"Hunink MGM","year":"2001"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.06.012"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12455463"},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Hoyle M, Pavey T, Ciani O, et al. Dasatinib, nilotinib, and standard dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses. 1st-line TKIs for chronic CML: final NICE report. Technology Assessment Report commissioned by the NIHR HTA Programme on behalf of the National Institute for Health and Clinical Excellence. Exeter, UK: Peninsula Technology Assessment Group (PenTAG), University of Exeter; 2011.","DOI":"10.3310\/hta16420"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.38"},{"issue":"1","key":"CIT0027","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022018184","volume":"112","author":"O\u2019Brien SG","year":"2008","journal-title":"Blood"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.9260"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011452"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-080689"},{"issue":"1","key":"CIT0031","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V66.1.39.39","volume":"112","author":"Kantarjian H","year":"2008","journal-title":"Blood"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-277152"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1996.tb01379.x"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20694"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-237115"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.12.3877"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462310000085"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200523050-00010"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00635.x"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.0329"},{"key":"CIT0041","first-page":"31","volume":"3","author":"Stephens J","year":"2010","journal-title":"Int J Gen Med"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-12-199712150-00005"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.04.012"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0380"},{"key":"CIT0046","volume-title":"Poster presented at 33rd Annual Meeting of the Society for Medical Decision Making (SMDM)","author":"Rochau U","year":"2011"},{"key":"CIT0047","volume-title":"Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia (CML) (part review of NICE technology appraisal guidance 70), and dasatinib and nilotinib for people with CML for whom treatment with imatinib has failed because of intolerance","author":"National Institute for Health and Clinical Excellence","year":"2012"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2010.495132"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-003-0205-2"},{"key":"CIT0050","volume":"4","author":"Siebert U","year":"2008","journal-title":"GMS Health Technol Assess"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2013.858149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T23:23:11Z","timestamp":1716074591000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2013.858149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,6]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,3,7]]},"published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.3109\/10428194.2013.858149"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2013.858149","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}